Personal Capital Advisors Corp Marker Therapeutics, Inc. Transaction History
Personal Capital Advisors Corp
- $20.6 Billion
- Q4 2022
A detailed history of Personal Capital Advisors Corp transactions in Marker Therapeutics, Inc. stock. As of the latest transaction made, Personal Capital Advisors Corp holds 25,712 shares of MRKR stock, worth $133,445. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25,712
Previous 25,712
-0.0%
Holding current value
$133,445
Previous $9,000
33.33%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding MRKR
# of Institutions
5Shares Held
472KCall Options Held
0Put Options Held
0-
Act Capital Management, LLC Wayne, PA354KShares$1.84 Million0.18% of portfolio
-
Ar Asset Management Inc70.7KShares$366,9330.07% of portfolio
-
American Portfolios Advisors Holbrook, NY21.2KShares$109,8720.0% of portfolio
-
Concourse Financial Group Securities, Inc. Birmingham, AL0Shares$00.0% of portfolio
About Marker Therapeutics, Inc.
- Ticker MRKR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 83,599,200
- Market Cap $434M
- Description
- Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of various T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications in the United States. Its MultiTAA-specific T cell technology is based on the manufact...